Cancer misinformation on social media.

Stacy Loeb, Aisha T Langford, Marie A Bragg, Robert Sherman, June M Chan
Author Information
  1. Stacy Loeb: Department of Urology, New York University Langone Health, New York, New York, USA. ORCID
  2. Aisha T Langford: Department of Family Medicine and Public Health Sciences, Wayne State University, Detroit, Michigan, USA.
  3. Marie A Bragg: Department of Population Health, New York University Langone Health, New York, New York, USA.
  4. Robert Sherman: Stakeholder Advisory Board, New York University Langone Health, New York, New York, USA.
  5. June M Chan: Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.

Abstract

Social media is widely used globally by patients, families of patients, health professionals, scientists, and other stakeholders who seek and share information related to cancer. Despite many benefits of social media for cancer care and research, there is also a substantial risk of exposure to misinformation, or inaccurate information about cancer. Types of misinformation vary from inaccurate information about cancer risk factors or unproven treatment options to conspiracy theories and public relations articles or advertisements appearing as reliable medical content. Many characteristics of social media networks-such as their extensive use and the relative ease it allows to share information quickly-facilitate the spread of misinformation. Research shows that inaccurate and misleading health-related posts on social media often get more views and engagement (e.g., likes, shares) from users compared with accurate information. Exposure to misinformation can have downstream implications for health-related attitudes and behaviors. However, combatting misinformation is a complex process that requires engagement from media platforms, scientific and health experts, governmental organizations, and the general public. Cancer experts, for example, should actively combat misinformation in real time and should disseminate evidence-based content on social media. Health professionals should give information prescriptions to patients and families and support health literacy. Patients and families should vet the quality of cancer information before acting upon it (e.g., by using publicly available checklists) and seek recommended resources from health care providers and trusted organizations. Future multidisciplinary research is needed to identify optimal ways of building resilience and combating misinformation across social media.

Keywords

References

  1. Am J Public Health. 2020 Oct;110(S3):S288-S289 [PMID: 33001723]
  2. Cureus. 2018 May 13;10(5):e2617 [PMID: 30027009]
  3. J Med Internet Res. 2019 Mar 07;21(3):e12441 [PMID: 30843866]
  4. Proc Natl Acad Sci U S A. 2021 Mar 2;118(9): [PMID: 33622786]
  5. Prog Palliat Care. 2021;29(5):264-271 [PMID: 34737490]
  6. JMIR Cancer. 2022 Aug 22;8(3):e36244 [PMID: 35994318]
  7. BJU Int. 2021 Oct;128(4):435-437 [PMID: 33811424]
  8. Cyberpsychol Behav Soc Netw. 2014 Dec;17(12):735-41 [PMID: 25489875]
  9. J Oncol Pract. 2018 Nov 1;:JOP1800367 [PMID: 30383479]
  10. J Med Internet Res. 2023 Jul 14;25:e46345 [PMID: 37450325]
  11. Eur Urol. 2019 Apr;75(4):564-567 [PMID: 30502104]
  12. Future Oncol. 2022 Mar;18(9):1133-1141 [PMID: 35109663]
  13. J Cancer Educ. 2015 Dec;30(4):699-703 [PMID: 25502853]
  14. J Med Internet Res. 2023 Sep 21;25:e45019 [PMID: 37733396]
  15. World J Urol. 2016 Jan;34(1):57-62 [PMID: 26590917]
  16. ESMO Open. 2021 Apr;6(2):100104 [PMID: 33838532]
  17. JMIR Cancer. 2023 Nov 27;9:e42123 [PMID: 38010774]
  18. Soc Sci Med. 2019 Nov;240:112552 [PMID: 31561111]
  19. Eur Urol Focus. 2020 May 15;6(3):440-444 [PMID: 31582312]
  20. JCO Oncol Pract. 2023 Mar;19(3):e389-e396 [PMID: 36626708]
  21. Digit Health. 2023 Oct 6;9:20552076231203799 [PMID: 37808240]
  22. Cancer Causes Control. 2023 Sep;34(9):813-827 [PMID: 37266764]
  23. Psychooncology. 2020 Jul;29(7):1185-1192 [PMID: 32364665]
  24. Rom J Ophthalmol. 2016 Oct-Dec;60(4):216-218 [PMID: 29450352]
  25. Curr Oncol. 2022 Nov 08;29(11):8483-8500 [PMID: 36354729]
  26. Am Soc Clin Oncol Educ Book. 2018 May 23;38:894-902 [PMID: 30231349]
  27. Prev Med. 2018 Aug;113:140-146 [PMID: 29787775]
  28. Patient Educ Couns. 2021 Feb;104(2):395-402 [PMID: 32771243]
  29. CA Cancer J Clin. 2024 Sep-Oct;74(5):453-464 [PMID: 38896503]
  30. BJU Int. 2019 Oct;124(4):701-706 [PMID: 31044493]
  31. JCO Oncol Pract. 2022 Aug;18(8):578-583 [PMID: 35344398]
  32. Soc Sci Med. 2022 Dec;314:115398 [PMID: 36327631]
  33. J Med Internet Res. 2021 Jan 20;23(1):e17187 [PMID: 33470931]
  34. J Med Internet Res. 2009 Nov 27;11(4):e48 [PMID: 19945947]
  35. J Med Internet Res. 2018 Jun 05;20(6):e203 [PMID: 29871850]
  36. Asia Pac J Oncol Nurs. 2019 Jan-Mar;6(1):24-27 [PMID: 30599012]
  37. JAMA Netw Open. 2020 Dec 1;3(12):e2031202 [PMID: 33369658]
  38. Oral Dis. 2016 Apr;22(3):202-8 [PMID: 26718020]
  39. J Med Libr Assoc. 2011 Jan;99(1):70-6 [PMID: 21243058]
  40. Cancer. 2021 Apr 15;127(8):1318-1324 [PMID: 33368215]
  41. J Cancer Policy. 2023 Jun;36:100418 [PMID: 36871667]
  42. Am J Clin Oncol. 2018 Sep;41(9):898-904 [PMID: 28537990]
  43. Eur Urol. 2018 Nov;74(5):644-650 [PMID: 30177286]
  44. Digit Health. 2022 Aug 2;8:20552076221116780 [PMID: 35935711]
  45. Health Inf Manag. 2023 Jan;52(1):3-17 [PMID: 33818176]
  46. J Health Commun. 2023 Oct 3;28(10):633-647 [PMID: 37665096]
  47. J Health Commun. 2021 Mar 4;26(3):184-193 [PMID: 33856286]
  48. Nutrients. 2018 Sep 08;10(9): [PMID: 30205540]
  49. JMIR Cancer. 2023 Jul 28;9:e43749 [PMID: 37505790]
  50. JAMA Intern Med. 2017 Mar 1;177(3):425-427 [PMID: 28114456]
  51. JMIR Form Res. 2023 Sep 6;7:e49452 [PMID: 37672310]
  52. J Health Commun. 2018;23(8):724-734 [PMID: 30160641]
  53. Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):554-9 [PMID: 26729863]
  54. J Public Health (Oxf). 2023 Jun 14;45(2):e339-e345 [PMID: 36102044]
  55. Am J Public Health. 2021 Jul;111(7):1348-1351 [PMID: 34014759]
  56. Health Commun. 2022 Nov;37(13):1622-1630 [PMID: 33840310]
  57. BMJ Open. 2020 Jul 5;10(7):e035626 [PMID: 32624466]
  58. Health Commun. 2021 Nov;36(13):1776-1784 [PMID: 32762260]
  59. Cancer Control. 2021 Jan-Dec;28:10732748211006055 [PMID: 33784858]
  60. JCO Oncol Pract. 2022 Aug;18(8):584-589 [PMID: 35357887]
  61. J Cancer Res Clin Oncol. 2019 Jul;145(7):1865-1875 [PMID: 31123824]
  62. J Med Internet Res. 2019 May 17;21(5):e13512 [PMID: 31102372]
  63. Inquiry. 2021 Jan-Dec;58:469580211035742 [PMID: 34399597]
  64. Clin J Oncol Nurs. 2020 Jun 1;24(3):290-295 [PMID: 32441693]
  65. Prostate Cancer Prostatic Dis. 2022 Apr;25(4):791-793 [PMID: 34853412]
  66. Eur Urol. 2021 Jan;79(1):56-59 [PMID: 33010986]
  67. Curr Hematol Malig Rep. 2018 Dec;13(6):581-587 [PMID: 30338458]

Grants

  1. R01 CA278997/NCI NIH HHS
  2. R01 CA278997/NIH HHS

MeSH Term

Humans
Social Media
Neoplasms
Communication
Information Dissemination

Word Cloud

Created with Highcharts 10.0.0mediamisinformationinformationsocialhealthcancerpatientsfamiliesinaccurateprofessionalsseeksharecareresearchriskpubliccontenthealth-relatedengagementegexpertsorganizationsCancerliteracySocialwidelyusedgloballyscientistsstakeholdersrelatedDespitemanybenefitsalsosubstantialexposureTypesvaryfactorsunproventreatmentoptionsconspiracytheoriesrelationsarticlesadvertisementsappearingreliablemedicalManycharacteristicsnetworks-suchextensiveuserelativeeaseallowsquickly-facilitatespreadResearchshowsmisleadingpostsoftengetviewslikessharesuserscomparedaccurateExposurecandownstreamimplicationsattitudesbehaviorsHowevercombattingcomplexprocessrequiresplatformsscientificgovernmentalgeneralexampleactivelycombatrealtimedisseminateevidence-basedHealthgiveprescriptionssupportPatientsvetqualityactinguponusingpubliclyavailablechecklistsrecommendedresourcesproviderstrustedFuturemultidisciplinaryneededidentifyoptimalwaysbuildingresiliencecombatingacrossdigitalfakenews

Similar Articles

Cited By